Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 943-980-3 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- other: Read Across
- Remarks:
- The end point is covered by test carried out on another AlkylPolyGlucoside esters considering the similar structure and a number of cross experiments which shown a similar behaviour. A rationale is available on it.
- Adequacy of study:
- key study
- Study period:
- April 12 - 27, 2011
- Reliability:
- 1 (reliable without restriction)
- Justification for type of information:
- The end point is covered by test carried out on another AlkylPolyGlucoside esters considering the similar structure and a number of cross experiments which shown a similar behaviour. A rationale is available on it.
Cross-reference
- Reason / purpose for cross-reference:
- read-across: supporting information
Reference
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
- Endpoint conclusion:
- no study available
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
The acute oral toxicity test was carried out on the substance.
The acute dermal toxicity was investigated on the substance
"Sulfonation products of (esterification products of C9-11 (branched and
linear) alkyl-(mono-, di- and tri-)glycosides with maleic anhydride)
with disodium sulfite" according to OECD guideline 402, EPA OPPTS
870.1200 (Acute Dermal Toxicity) and EC 440/2008, following GLP
conditions.
The acute oral toxicity test, performed in the year 1993, did not follow the OECD. However the conditions applied in the study are acceptable and the result shows clearly that the substance is not toxic (LD50 > 5000 mg/kg b.w.) .
The acute dermal toxicity test was performed in the year 2011, under GLP conditions and following the OECD guidelines. Under the conditions of the study, neither mortality nor signs of toxicity but minor signs of irritation were observed.
The dermal LD50 was determined to be > 2000 mg / kg body weight (based on the active components).
Justification for selection of acute toxicity – oral endpoint
The study refers to "D-Glucopyranose, oligomers, monosulfosuccinate,
coco alkyl glycosides, sodium salts", a structurally related substance
to "Sulfonation products of (esterification products of C9-11 (branched
and linear) alkyl-(mono-, di- and tri-)glycosides with maleic anhydride)
with disodium sulfite". The acute oral toxicity test, performed in the
year 1993, did not follow the OECD. However the conditions applied in
the study are acceptable and the result shows clearly that the substance
is not toxic.
Justification for selection of acute toxicity – dermal endpoint
Study was performed with "Sulfonation products of (esterification
products of C9-11 (branched and linear) alkyl-(mono-, di- and
tri-)glycosides with maleic anhydride) with disodium sulfite". The study
was carried out in GLP and according to an OECD standard method.
Basing on the results above reported and following the REGULATION (EC) No 1272/2008 (EU Regulation on Classification, Labelling and Packaging of substances and mixtures) the substance "Sodium salt of esterification products of C10-C16 (even numbered) alkylpolyglycosides with citric acid" does not required classification for acute toxicity.
Oral Toxicity:
Classification : not required
Signal word : none
Hazard statement (Oral) : none
Dermal toxicity
Classification : Not required
Signal word : None
Hazard statement : None
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 011
- Report date:
- 2011
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1200 (Acute Dermal Toxicity)
- Qualifier:
- according to guideline
- Guideline:
- other: EC 440/2008
- Principles of method if other than guideline:
- Commission Regulation (EC) No 440/2008, L 142, Annex Part B of 30 May 2008 laying down test methods pursuant to Regulation (EC) No. 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- Sulfonation products of disodium sulfite with (esterification products of C9-11 (branched and linear) Alkyl Polyglycosides with maleic anhydride)
- EC Number:
- 700-855-6
- IUPAC Name:
- Sulfonation products of disodium sulfite with (esterification products of C9-11 (branched and linear) Alkyl Polyglycosides with maleic anhydride)
- Details on test material:
- Batch No.: PIC 484
CAS No.: 1228577-41-0
Colour: Yellow
Physical State: Liquid (50% in water)
Purity: 50% (in water)
Expiry Date: October 2012
Storage Conditions: at room temperature, protected from light
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Species/strain: healthy rats, WISTAR rats Crl: WI(Han) (full barrier)
Source: Charles River, 97633 Sulzfeld, Germany
Sex: male and female (non-pregnant and nulliparous).
Number of animals: 5 male and 5 female
Age at the beginning of the study: males: 8 weeks old; females: 11 weeks old
Body weight on the day of administration: males: 225 – 250 g; females: 210 – 233 g
The animals were derived from a controlled full-barrier maintained breeding system (SPF).
Housing and Feeding Conditions
- Full barrier in an air-conditioned room
- Temperature: 22 ± 3 °C
- Relative humidity: 55 ± 10%
- Artificial light, sequence being 12 hours light, 12 hours dark
- Air change: 10 x / hour
- Free access to Altromin 1324 maintenance diet for rats and mice (lot no. 1307)
- Free access to tap water, sulphur acidified to a pH value of approximately 2.8 (drinking water, municipal residue control, microbiological controls at regular intervals)
- The animals were kept individually in IVC cages, type III H, polysulphone cages on Altromin saw fibre bedding (lot no. 24/11/2010)
- Adequate acclimatisation period (at least five days)
Approximately 24.5 hours before the test, the fur was removed from the dorsal area of the trunk by using an electric clipper. Care was taken to avoid abrading the skin, and only animals with healthy intact skin were used.
No less than 10% of the body surface was cleared for the application.
Administration / exposure
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- The test item was applied at a single dose, uniformly over an area which was approximately 10% of the total body surface.
The test item was held in contact with the skin by a dressing throughout a 24-hour period. The dressing consisted of a gauze-dressing and non-irritating tape and was fixed with an additional dressing in a suitable manner.
At the end of the exposure period the residual test item was removed by using aqua ad injectionem. - Duration of exposure:
- 24 hours
- Doses:
- 2000 mg/kg
The active component of the test item is diluted in water (50 %); to assure the dose of 2000 mg/kg a correction factor of 2 was considered for preparation of the dressing with the test item, which has been consequently applied at a dose of 4000 mg/kg body weight. - No. of animals per sex per dose:
- 5
- Details on study design:
- All animals were observed for 14 days after dosing.
Results and discussion
Effect levels
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- act. ingr.
- Mortality:
- No mortality
- Clinical signs:
- No treatment-related effects were observed
- Gross pathology:
- No treatment-related effects were observed
- Other findings:
- No erythema or oedema was observed. Desquamation was observed in 1 out of 5 female animals.
Eschar was observed in 5 out of 5 male and 4 out of 5 female animals. Scratches were observed in 3 out of 5 male animals.
All signs of irritation were reversible within the observation period.
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Under the conditions of the present study, single dermal application of the test item to rats at a dose of 2000 mg/kg body weight (based on the active components) was associated with no mortality and neither signs of toxicity but minor signs of irritation.
The dermal LD50 was determined to be > 2000 mg/kg body weight (based on the active components). - Executive summary:
Under the conditions of the present study, single dermal application of the test item to rats at a dose of 2000 mg/kg body weight (based on the active components) was associated with no mortality and neither signs of toxicity but minor signs of irritation.
The dermal LD50 was determined to be > 2000 mg/kg body weight (based on the active components).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.